By month 4 (week 16), over 85% of patients reported minimal to no side effects
Serious adverse events requiring immediate medical attention include: Pancreatitis: Severe abdominal pain, sometimes radiating to the back, with or without vomiting Gallbladder disease: Right upper quadrant pain, nausea, vomiting Acute kidney injury: Decreased urine output, swelling, fatigue Thyroid C-cell tumors (boxed warning for tirzepatide): Neck mass, difficulty swallowing, persistent hoarseness Metabolic considerations include the risk of hypoglycemia, particularly in patients with type 2 diabetes taking other glucose-lowering medications
However, peptides cannot be injected or utilized in any sort of research in the dry powdered state
Proteins: Two pounds of chicken breast
EllieMD claims sublingual delivery bypasses much of the digestive system, with bioavailability potentially reaching 40%